MORF - Morphic - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

Morphic's activity chart (see below) currently has 58 price targets and 37 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 33.22% of the time, taking 95.9 days on average.

Most recent stock forecast was given by GREGORY RENZA from TRUIST on 26-Jul-2024. First documented stock forecast 22-Jul-2019.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 26-Jul-2024

$57

$57

2 years 3 months 27 days ago
(26-Jul-2024)

2/9 (22.22%)

$0.45 (0.80%)

63

Hold Since 25-Sep-2023

$57

$27

2 years 4 months ago
(22-Jul-2024)

4/6 (66.67%)

$0.41 (0.72%)

105

Buy Since 25-Apr-2023

$57

$52

2 years 4 months 13 days ago
(09-Jul-2024)

1/3 (33.33%)

$1.33 (2.39%)

284

Buy Since 22-Jul-2019

$60

$27

2 years 8 months 9 days ago
(13-Mar-2024)

1/2 (50%)

$25.4 (73.41%)

16

Buy Since 31-Mar-2022

$66

$68

2 years 8 months 14 days ago
(08-Mar-2024)

0/2 (0%)

$28.82 (77.51%)

Show more analysts

Please expand the browser size to see the chart

What is MORF (Morphic) average time for price targets to be met?

On average it took 96 days for the stock forecasts to be reached, with an average price target met ratio of 33.22%.

Which analyst most recently updated their price target on MORF (Morphic)?

Gregory Renza

Which analyst has the most public recommendations on MORF (Morphic)?

Gregory Renza works at TRUIST and has 11 price targets and 6 ratings on MORF

Which analyst is the currently most bullish on MORF (Morphic)?

Do Kim with the highest potential upside of $45.01

Which analyst is the currently most reserved on MORF (Morphic)?

Thomas Smith with the lowest potential downside of -$0.99
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?